EloA promotes HEL polyploidization upon PMA stimulation through enhanced ERK1/2 activity-Reference-Cited by-同舟云学术

EloA promotes HEL polyploidization upon PMA stimulation through enhanced ERK1/2 activity

Published:2021-10-26 Issue: Volume: Page:1-9
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Hu Lanyue¹,Zhang Weiwei¹,Xiang Zheng¹,Wang Yali¹,Zeng Cheng¹,Wang Xiaojie¹,Tan Chengning¹,Zhang Yichi¹,Li Fengjie¹,Xiao Yanni¹,Zhou Luping¹,Li Jiuxuan¹,Wu Chun¹,Xiang Yang¹,Xiang Lixin¹,Zhang Xiaomei¹,Wang Xueying¹,Yang Wuchen²,Chen Maoshan³^ORCID,Ran Qian¹,Li Zhongjun¹,Chen Li¹^ORCID

Affiliation:

1. Laboratory of Radiation Biology, Department of Blood Transfusion, Laboratory Medicine Center, the Second Affiliated Hospital, Army Medical University, Chongqing, China

2. Department of Hematology, The Second Affiliated Hospital, Army Medical University, Chongqing, China

3. Australian Centre for Blood Diseases (Acbd), Clinical Central School, Monash University, Melbourne, Australia

Funder

no funding

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2021.1988548

Reference42 articles.

1. Genomic landscape of megakaryopoiesis and platelet function defects

2. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release

3. Roads to polyploidy: The megakaryocyte example

4. Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage

5. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-ĸB pathway;Journal of Pharmaceutical Analysis;2024-07

2. Alnustone promotes megakaryocyte differentiation and platelet production via the interleukin-17A/interleukin-17A receptor/Src/RAC1/MEK/ERK signaling pathway;European Journal of Pharmacology;2024-05